These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24111531)

  • 1. Increased efficacy of omalizumab in atopic dermatitis patients with wild-type filaggrin status and higher serum levels of phosphatidylcholines.
    Hotze M; Baurecht H; Rodríguez E; Chapman-Rothe N; Ollert M; Fölster-Holst R; Adamski J; Illig T; Ring J; Weidinger S
    Allergy; 2014 Jan; 69(1):132-5. PubMed ID: 24111531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omalizumab treatment in severe adult atopic dermatitis.
    Thaiwat S; Sangasapaviliya A
    Asian Pac J Allergy Immunol; 2011 Dec; 29(4):357-60. PubMed ID: 22299316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study.
    Sheinkopf LE; Rafi AW; Do LT; Katz RM; Klaustermeyer WB
    Allergy Asthma Proc; 2008; 29(5):530-7. PubMed ID: 18926061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dermatological implications of omalizumab, an anti-IgE antibody].
    Di Lucca-Chrisment J
    Rev Med Suisse; 2015 Apr; 11(468):779-80, 782-3. PubMed ID: 26021140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-immunoglobulin E in the treatment of refractory atopic dermatitis.
    Kim DH; Park KY; Kim BJ; Kim MN; Mun SK
    Clin Exp Dermatol; 2013 Jul; 38(5):496-500. PubMed ID: 23083013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis.
    Incorvaia C; Pravettoni C; Mauro M; Yacoub MR; Tarantini F; Riario-Sforza GG
    Monaldi Arch Chest Dis; 2008 Jun; 69(2):78-80. PubMed ID: 18837422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-immunoglobulin e in the treatment of refractory atopic dermatitis.
    Amrol D
    South Med J; 2010 Jun; 103(6):554-8. PubMed ID: 20710140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IgE therapy and severe atopic dermatitis: a pediatric perspective.
    Lacombe Barrios J; Bégin P; Paradis L; Hatami A; Paradis J; Des Roches A
    J Am Acad Dermatol; 2013 Nov; 69(5):832-834. PubMed ID: 24124824
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a randomized, placebo-controlled clinical trial.
    Iyengar SR; Hoyte EG; Loza A; Bonaccorso S; Chiang D; Umetsu DT; Nadeau KC
    Int Arch Allergy Immunol; 2013; 162(1):89-93. PubMed ID: 23816920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab for the treatment of atopic dermatitis.
    Fernández-Antón Martínez MC; Leis-Dosil V; Alfageme-Roldán F; Paravisini A; Sánchez-Ramón S; Suárez Fernández R
    Actas Dermosifiliogr; 2012 Sep; 103(7):624-8. PubMed ID: 22056257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow-up of omalizumab therapy.
    Velling P; Skowasch D; Pabst S; Jansen E; Tuleta I; Grohé C
    Eur J Med Res; 2011 Sep; 16(9):407-10. PubMed ID: 22024441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential combined therapy with omalizumab and rituximab: a new approach to severe atopic dermatitis.
    Sánchez-Ramón S; Eguíluz-Gracia I; Rodríguez-Mazariego ME; Paravisini A; Zubeldia-Ortuño JM; Gil-Herrera J; Fernández-Cruz E; Suárez-Fernández R
    J Investig Allergol Clin Immunol; 2013; 23(3):190-6. PubMed ID: 23967758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-IgE--emerging opportunities for Omalizumab.
    Babu KS; Polosa R; Morjaria JB
    Expert Opin Biol Ther; 2013 May; 13(5):765-77. PubMed ID: 23517576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Success of omalizumab as monotherapy in adult atopic dermatitis: case report and discussion of the high-affinity immunoglobulin E receptor, FcepsilonRI.
    Forman SB; Garrett AB
    Cutis; 2007 Jul; 80(1):38-40. PubMed ID: 17725062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
    Maurer M; Altrichter S; Bieber T; Biedermann T; Bräutigam M; Seyfried S; Brehler R; Grabbe J; Hunzelmann N; Jakob T; Jung A; Kleine-Tebbe J; Mempel M; Meurer M; Reich K; Ruëff F; Schäkel K; Sengupta K; Sieder C; Simon JC; Wedi B; Zuberbier T; Mahler V; Staubach P
    J Allergy Clin Immunol; 2011 Jul; 128(1):202-209.e5. PubMed ID: 21636116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-IgE antibody omalizumab as a probe to investigate the role of IgE in pathology.
    Mauro M; Incorvaia C; Formigoni C; Elia R; Russello M; Pellegrino D
    Panminerva Med; 2012 Dec; 54(4):305-12. PubMed ID: 23123583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels.
    Belloni B; Ziai M; Lim A; Lemercier B; Sbornik M; Weidinger S; Andres C; Schnopp C; Ring J; Hein R; Ollert M; Mempel M
    J Allergy Clin Immunol; 2007 Nov; 120(5):1223-5. PubMed ID: 17936892
    [No Abstract]   [Full Text] [Related]  

  • 18. Current status of therapy with omalizumab in children.
    Baena-Cagnani CE; Gómez RM
    Curr Opin Allergy Clin Immunol; 2014 Apr; 14(2):149-54. PubMed ID: 24535142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria.
    Song CH; Stern S; Giruparajah M; Berlin N; Sussman GL
    Ann Allergy Asthma Immunol; 2013 Feb; 110(2):113-7. PubMed ID: 23352531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.
    Metz M; Ohanyan T; Church MK; Maurer M
    J Dermatol Sci; 2014 Jan; 73(1):57-62. PubMed ID: 24060603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.